about
Pantoprazole decreases cell viability and function of human osteoclasts in vitroVEGF released from a fibrin biomatrix increases VEGFR-2 expression and improves early outcome after ischaemia-reperfusion injury.Controlled delivery systems: from pharmaceuticals to cells and genes.Presence of starch enhances in vitro biodegradation and biocompatibility of a gentamicin delivery formulation.Silk fibroin microparticles as carriers for delivery of human recombinant bone morphogenetic protein-2: in vitro and in vivo bioactivity.Redifferentiation of aged human articular chondrocytes by combining bone morphogenetic protein-2 and melanoma inhibitory activity protein in 3D-culture.Microneedle physical contact as a therapeutic for abnormal scarsSynthesis and functionalization of superparamagnetic poly-ε-caprolactone microparticles for the selective isolation of subpopulations of human adipose-derived stem cellsmiRNAs in bone tissue correlate to bone mineral density and circulating miRNAs are gender independent in osteoporotic patients.A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents.BMP-2-transduced human bone marrow stem cells enhance neo-bone formation in a rat critical-sized femur defect.* Fabrication and Characterization of Biphasic Silk Fibroin Scaffolds for Tendon/Ligament-to-Bone Tissue Engineering.Co-Culture with Human Osteoblasts and Exposure to Extremely Low Frequency Pulsed Electromagnetic Fields Improve Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.Oxygen-distribution within 3-D collagen I hydrogels for bone tissue engineeringDevelopment, Characterization and In Vitro Biological Properties of Scaffolds Fabricated From Calcium Phosphate NanoparticlesChondrocyte Culture Parameters for Matrix-Assisted Autologous Chondrocyte Implantation Affect Catabolism and Inflammation in a Rabbit Model
P50
Q35271665-D95D64F1-CC6F-4A42-A303-D8C9202BDC92Q35896387-0DA29DB3-08F7-4C06-8BC0-7D3142D44761Q37855597-C5F37FC0-F6D1-4173-9972-AB0ACCFCB3C8Q38875375-0E76C16A-F421-4F7A-835D-577A8B5210ABQ39767493-7BDB542C-FD90-4A1A-A0F1-727C29337479Q41006395-5CF3BD62-32E3-46C0-8358-31C19590029FQ41411935-8E213965-FF5B-4526-B403-6A7D40CBBE07Q42741503-B2921D56-DDD6-4447-8F30-FFC69086D8F8Q46930678-1402C606-5A64-4667-AD9B-2E9FEBA59A40Q47964101-799F38E3-49DF-4E7A-8C0E-2707B2940A66Q48215559-B7536BA9-79FE-4E42-963C-33D6F3880E7AQ48813608-9FE6F139-57A6-4137-9BF0-31C42DE42194Q55001754-8231A769-2830-40D6-ABA3-85022631A8D6Q61188703-A84E2C45-DAD4-454B-B485-857CFE9FCA1CQ64055387-C8EE3A4E-8636-4CBE-87F3-B3413A6D99A6Q64112638-6BADEF5A-4B8D-4DB8-BFEB-65BDDFB244B9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elizabeth R Balmayor
@ast
Elizabeth R Balmayor
@en
Elizabeth R Balmayor
@es
Elizabeth R Balmayor
@nl
Elizabeth R Balmayor
@sl
type
label
Elizabeth R Balmayor
@ast
Elizabeth R Balmayor
@en
Elizabeth R Balmayor
@es
Elizabeth R Balmayor
@nl
Elizabeth R Balmayor
@sl
altLabel
ER. Balmayor
@en
Elizabeth Rosado Balmayor
@en
prefLabel
Elizabeth R Balmayor
@ast
Elizabeth R Balmayor
@en
Elizabeth R Balmayor
@es
Elizabeth R Balmayor
@nl
Elizabeth R Balmayor
@sl
P108
P1053
N-9283-2015
P106
P21
P2798
P31
P3829
P496
0000-0002-0484-4847